Approval · Notice of Compliance 36062 · 2025
FLAGYSTATIN: Notice of Compliance 36062
Issued September 25, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36062
- Date
- September 25, 2025
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph with new safety information
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLAGYSTATIN | Not yet assigned | — |
Medicinal ingredients
- METRONIDAZOLE 500 MG per OVULE
- NYSTATIN 100,000 UNIT per OVULE